A CLINICAL TRIAL TO STUDY THE EFFECT OF PANCHA PASHANA CHENDHURAM (INT)KURUNTHOTTI OIL(EXT)VARAMAM THERAPY IN PATIENTS WITH NECK PAIN(CERVICAL SPONDYLOSIS)

AN OPEN COMPARATIVE CLINICAL EVALUATION ON "SAGANAVADHAM" (CERVICAL SPONDYLOSIS) WITH SIDDHA TRAIL DRUGS "PANCHA PASHANA CHENDHURAM" (INTERNAL), "KURUNTHOTTI THAILAM" (EXTERNAL) AND "VARMAM THERAPY"

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008404

Enrollment

Registered

2017-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SAGANAVADHAM (CERVICAL SPONDYLOSIS)

Interventions

Intervention1: PANCHA PASHANA CHENDHURAM(INTERNAL), KURUNTHOTTI OIL(EXTERNAL): 20 Patients treated with pancha pashana chendhuram, 65mg,oral administration,twice daily,kurunthotti oil(external) applic

Eligibility

Inclusion criteria

Inclusion criteria: 1.Neck stiffness 2.Pain in the nape of the neck 3.Radiating pain to the upper limbs up to the tip of the fingers 4.With or without numbness in the upper limbs 5.Limitations of movements 6.Willing to sign consent form

Exclusion criteria

Exclusion criteria: 1.Atlanto axial subluxation 2.Scalene syndrome 3.Adhesive capsulitis 4.Supraspinatus tendinitis 5.Congenital deformities of spine like Torticolis, spina bifida & scoliosis 6.Sero Negative Spondylarthropathy like Ankylosing spondylitis, Polyarthritis etc 7.Syringomyelia 8.Cardiac diseases 9.Pregnant women and lactating mothers 10.Neoplasms 11.Meningitis 12.Wry neck 13.TB in cervical spine( caries spine) 14.Patients with any other serious systemic illness

Design outcomes

Primary

Measure	Time frame
1.Pain reduction is evidenced by pain assessment scale(visual analogue scale). ï?§ Comparing the clinical symptoms before and after treatment. Timepoint: 12 months	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr M Rajanandhini

Govt siddha medical college

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026